{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T04:15:28Z","timestamp":1749701728386,"version":"3.41.0"},"reference-count":1,"publisher":"Massachusetts Medical Society","issue":"15","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["N Engl J Med"],"published-print":{"date-parts":[[2024,4,18]]},"DOI":"10.1056\/nejmc2402133","type":"journal-article","created":{"date-parts":[[2024,4,17]],"date-time":"2024-04-17T21:00:45Z","timestamp":1713387645000},"page":"1440-1441","source":"Crossref","is-referenced-by-count":1,"title":["Four-Drug Therapy for Multiple Myeloma"],"prefix":"10.1056","volume":"390","member":"150","reference":[{"key":"e_1_2_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2312054"}],"container-title":["New England Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nejm.org\/doi\/pdf\/10.1056\/NEJMc2402133","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T22:44:55Z","timestamp":1749681895000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.nejm.org\/doi\/10.1056\/NEJMc2402133"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,18]]},"references-count":1,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2024,4,18]]}},"alternative-id":["10.1056\/NEJMc2402133"],"URL":"https:\/\/doi.org\/10.1056\/nejmc2402133","relation":{},"ISSN":["0028-4793","1533-4406"],"issn-type":[{"type":"print","value":"0028-4793"},{"type":"electronic","value":"1533-4406"}],"subject":[],"published":{"date-parts":[[2024,4,18]]}}}